Tutorials
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

CHF 77.56 (0%) Aug 12
P/E:
45.37
P/B:
10.93
Market Cap:
CHF 61.17B ($ 64.97B)
Enterprise V:
CHF 60.39B ($ 64.14B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap CHF:
61.17B
Market Cap $:
64.97B
PE Ratio:
45.37
Avg Vol (2-Month):
-
Enterprise Value CHF:
60.39B
Enterprise Value $:
64.14B
PB Ratio:
10.93
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Edwards Lifesciences Corp
NAICS : 339113 SIC : 3842
One Edwards Way, Irvine, CA, USA, 92614
Description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.
Name Current Vs Industry Vs History
Cash-To-Debt 2.22
Equity-to-Asset 0.71
Debt-to-Equity 0.12
Debt-to-EBITDA 0.36
Interest Coverage 2059
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 18.46
Distress
Grey
Safe
Beneish M-Score -2.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.37
Quick Ratio 2.6
Cash Ratio 1.56
Days Inventory 226.66
Days Sales Outstanding 42.21
Days Payable 49.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.1

Financials (Next Earnings Date:2022-10-27 Est.)

LTS:0REN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 5,013.175
EPS (TTM) (CHF) 2.165
Beta 0.67
Volatility % 17.76
14-Day RSI 0
14-Day ATR (CHF) 0
20-Day SMA (CHF) 77.55964
12-1 Month Momentum % 0
52-Week Range (CHF) 77.55964 - 77.55964
Shares Outstanding (Mil) 619.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Edwards Lifesciences Corp Filings

Document Form Filing Date
No Filing Data